semaglutide bridgeport Weight Loss Injections Tualatin, OR Ozempic Weight Loss Injections &

The FDA confiscated these units on April 9, 2025, and has launched an investigation in collaboration with Novo Nordisk, the manufacturer of Ozempic

In addition to enforcing its patent rights, Novo has also been litigating to protect its trademarks

Clinical studies have shown that many people lose an average of 10% to 15% of their starting body weight over time when semaglutide is used consistently alongside lifestyle changes

Ongoing monitoring is essential for safe GLP-1 use

In addition to its use in diabetes management, semaglutide has gained attention for its application in weight management, particularly with the brand Wegovy, which delivers higher doses specifically designed for chronic weight management